st. jude medical

Jefferies & Company has published a research report on St. Jude Medical (NYSE: STJ) after the company talks suggested a sooner launch of its Quadra CRT-D device in the U.S. at the Boston AF Meeting. In the report, Jefferies writes "Several clinicians and industry reps we spoke with at the...

Jefferies & Company has raised the price target on St. Jude Medical (NYSE: STJ) from $46 to $49 and maintains its Buy rating.

Jefferies & Company has raised the price target on St. Jude Medical (NYSE: STJ) from $46 to $49 and maintains its Buy rating.

Morgan Stanley reports today that increasing risks to revenue outlook amid a softening CRM market drive its downgrade on shares of St. Jude Medical, Inc. (NYSE: STJ) to UW. “St. Jude's reliance on the cardiac rhythm management (CRM) market (nearly 60% of 2010e sales) has long been a key investor...

Wells Fargo makes the following EPS revisions: FY10 FY11 Old New Old New Phillips-Van Heusen(NYSE: PVH) $3.80 $3.95 $4.68 $4.90 Vera Bradley Inc.(NASDAQ: VRA) $1.03 $1.07 $1.07 $1.15 Boston Scientific (NYSE: BSX...

Collins Stewart has published a research report on the Medical Devices and Hospital Supplies sector and reports on its top picks for the group. In the report, Collins Stewart writes "We believe that FDA approval of Protecta ICD and Revo could provide MDT with an incremental $50 million (1% market...

Goldman Sachs updates its outlook on St. Jude Medical (NYSE: STJ) following STJ's acquisition of AGA Medical for $1.25 billion. In a note to clients, Goldman Sachs writes, "The AGA Medical acquisition is accretive to STJ's top-line growth rate, as this business had been growing in the low-double...

St. Jude Medical, Inc. (NYSE: STJ)'s third quarter sales were just below the Street but another quarter of no growth in SG&A enabled a $0.04 “beat,” Citigroup reports. “It's starting to look clear again that with slowing end markets and increasing competition in AF and neuromodulation that STJ'...

Piper Jaffray is reporting that in the past few months, the U.S. dollar has weakened considerably against the other major currencies including the euro and yen. “At current exchange rates, the dollar has weakened 12% against the euro and 7.5% against the yen since the end of Q2,” Piper Jaffray...

Initiation coverage from Deutsche Bank for September 10 is as follows: St. Jude Medical (NYSE: STJ) Initiate with Hold Rating and $39 price target Boston Scientific (NYSE: BSX) Initiate with Hold rating and $6.30 price target. Zimmer Holdings (NYSE: ZMH) Initiate with Hold rating and $53 price...

St. Jude Medical (NYSE: STJ) Initiate with Hold Rating and $39 price target Boston Scientific (NYSE: BSX) Initiate with Hold rating and $6.30 price target. Zimmer Holdings (NYSE: ZMH) Initiate with Hold rating and $53 price target CareFusion Corporation (NYSE: CFN) Initiate with Hold rating and $23...